Day One Biopharmaceuticals (DAWN) Prices 10M Share Offering at $15

Day One Biopharmaceuticals, Inc. (Nasdaq: DAWN) announced the pricing of its upsized underwritten public offering of 10,000,000 shares of its common stock at a public offering price of $15.00 per share. All shares of common stock are being offered by Day One. The gross proceeds to Day One from the offering, before deducting underwriting discounts and commissions and other offering expenses, are expected to be $150.0 million. In addition, Day One has granted the underwriters a 30-day option to purchase up to an additional 1,500,000 shares of its common stock at the public offering price, less underwriting discounts and commissions. The offering is expected to close on or about June 17, 2022, subject to the satisfaction of customary closing conditions.

J.P. Morgan, Cowen and Piper Sandler are acting as the joint book-running managers for the offering. Wedbush PacGrow is acting as the lead manager for the offering.

You May Also Be Interested In

• Zentalis Pharmaceuticals prices $80.5M public stock offering
• TD Cowen: 'CABA appears well-positioned to scale commercially with minimal capital investment'
• AI/ML Innovations plans $2M private placement on the CSE